Nutriband (NASDAQ:NTRB) Shares Up 6.1% – Here’s Why

Nutriband Inc. (NASDAQ:NTRB) shot up 6.1% during trading on Tuesday . The company traded as high as $7.15 and last traded at $7.15. 21,094 shares were traded during mid-day trading, a decline of 34% from the average session volume of 31,957 shares. The stock had previously closed at $6.74.

Nutriband Trading Up 6.1%

The stock has a fifty day moving average of $7.10 and a 200 day moving average of $6.70. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.70 and a current ratio of 4.78. The company has a market capitalization of $86.01 million, a PE ratio of -2.49 and a beta of 1.13.

Nutriband (NASDAQ:NTRB) last posted its quarterly earnings results on Tuesday, September 9th. The company reported ($2.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($1.95). Nutriband had a negative return on equity of 85.40% and a negative net margin of 398.29%.The business had revenue of $0.62 million during the quarter, compared to analysts’ expectations of $0.71 million. As a group, sell-side analysts predict that Nutriband Inc. will post -0.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nutriband stock. US Bancorp DE bought a new stake in Nutriband Inc. (NASDAQ:NTRB) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 4,798 shares of the company’s stock, valued at approximately $29,000. 19.70% of the stock is currently owned by hedge funds and other institutional investors.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.